US ETFSPDR· XBI· S&P Biotech Select

SPDR S&P Biotech ETF

Issuer: State Street · Expense 0.35%

1Y Return

76.3%

YTD Return

10.9%

3Y CAGR

76.6%

5Y CAGR

76.6%

1Y Volatility

25.3%

1Y Sharpe

2.89

Max Drawdown

-9.7%

$134.71

Profile

Asset class: equity

Region: US

Currency exposure: native

Monthly dividend: No

Leveraged: No

Pension-eligible: No

ISA-eligible: No

Themes

theme-biotechsector-healthcare

Related Inteliview Articles (1)

Eli Lilly's Next-Gen Obesity Drug Retatrutide Already Circulating in Gray Market Before FDA Approval

Eli Lilly's retatrutide is circulating through compounding pharmacies in a gray market ahead of FDA …

May 8, 2026

Holdings — coming soon

US ETF holdings will be backfilled from issuer-direct sources (SPDR/iShares/Vanguard CSV feeds) and SEC N-PORT filings in Phase 3.3. Once available, the Wall Street guru × constituent overlap widget will render here.

Distribution history — Phase 2

Will appear once SEIBro distribution data is loaded.

Gurus holding this ETF — Phase 4

Will appear once 13F holdings data is joined in.

Metrics as of 2026-05-09 · Last close 2026-05-08